Alpha Cognition Inc. Common Stock Share Price & Technical Analysis
ACOG · $5.88 (+0.51%)
Healthcare / Biotechnology
$5.88
+0.51%
Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatme…
Price chart
Seasonality
May has 1 positive and 1 negative years (last 3 years shown)
-3% return in May, 69% avg return in past 3 year May month.
-2% return in 2026, 0% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -27% | 25% | -5% | 9% | -3% | – | – | – | – | – | – | – | -2% |
| 25 | -5% | 5% | -15% | 6% | 69% | -6% | -2% | -10% | -22% | -10% | -2% | 8% | 17% |
| 24 | – | – | – | – | – | – | – | – | – | – | -6% | -12% | -18% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Neutral
Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. Alpha Cognition Inc. was founded in 2000 and is headquartered in Grapevine, Texas.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$127.38M
P/E ratio
—
52W high
$11.54
52W low
$4.50
Volume
16,228
Beta
2.39
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Alpha Cognition Inc. Common Stock share price today?
- Alpha Cognition Inc. Common Stock (ACOG) last traded around $5.88 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does ACOG have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for ACOG. Download the app for real-time alerts.
- How can I analyze Alpha Cognition Inc. Common Stock stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.